Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Standing

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|August 22, 2009
Prospective observational study of adverse drug reactions to diclofenac in childrenJoseph F Standing, Kuan Ooi, Simon Keady, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infectionsDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 30, 2018
Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth mediaAndrew Mead, Peter Lees, John Mitchell, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2021
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteersZoe Kane, Roberto Picetti, Alison Wilby, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic ModelFrank Kloprogge, Louise F Hill, John Booth, et al.
Advanced Drug Delivery Reviews|January 21, 2014
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyCharlotte I S Barker, Eva Germovsek, Rollo L Hoare, et al.
British Journal of Clinical Pharmacology|August 17, 2022
Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case studyWen Yao Mak, Qing Xi Ooi, Cintia Valeria Cruz, et al.
British Journal of Clinical Pharmacology|February 21, 2020
Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioningBelén P Solans, Robert Chiesa, Bilyana Doncheva, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected dataEva Germovsek, Leanne Osborne, Flora Gunaratnam, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2023
Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral DosingZoe Kane, Iek Cheng, Orlagh McGarrity, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|August 22, 2009
Prospective observational study of adverse drug reactions to diclofenac in childrenJoseph F Standing, Kuan Ooi, Simon Keady, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infectionsDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 30, 2018
Differential susceptibility to tetracycline, oxytetracycline and doxycycline of the calf pathogens Mannheimia haemolytica and Pasteurella multocida in three growth mediaAndrew Mead, Peter Lees, John Mitchell, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 4, 2021
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteersZoe Kane, Roberto Picetti, Alison Wilby, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic ModelFrank Kloprogge, Louise F Hill, John Booth, et al.
Advanced Drug Delivery Reviews|January 21, 2014
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyCharlotte I S Barker, Eva Germovsek, Rollo L Hoare, et al.
British Journal of Clinical Pharmacology|August 17, 2022
Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case studyWen Yao Mak, Qing Xi Ooi, Cintia Valeria Cruz, et al.
British Journal of Clinical Pharmacology|February 21, 2020
Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioningBelén P Solans, Robert Chiesa, Bilyana Doncheva, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected dataEva Germovsek, Leanne Osborne, Flora Gunaratnam, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2023
Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral DosingZoe Kane, Iek Cheng, Orlagh McGarrity, et al.
Pageof 14